XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2017/04/29/celltrion-and-nippon-kayaku-strike-deal-for-rituxan-biosimilar/20%Monthly2018-01-09 16:48
https://www.bigmoleculewatch.com/2017/04/28/dance-fever-a-recap-of-recent-bpcia-litigation/20%Monthly2018-06-04 14:25
https://www.bigmoleculewatch.com/2017/04/28/pfizer-files-for-ipr-of-two-biogen-patents-directed-to-rituximab/20%Monthly2018-01-09 16:53
https://www.bigmoleculewatch.com/2017/04/27/apotex-cp-seeks-heighten-regulatory-requirements-for-competition/20%Monthly2018-01-09 16:56
https://www.bigmoleculewatch.com/2017/04/26/breaking-news-supreme-court-heard-oral-arguments-in-amgen-v-sandoz/20%Monthly2018-05-25 15:04
https://www.bigmoleculewatch.com/2017/04/26/fresenius-kabi-acquires-merck-kgaas-biosimilars-business/20%Monthly2018-01-09 16:56
https://www.bigmoleculewatch.com/2017/04/26/analysis-supreme-court-oral-argument-in-sandoz-v-amgen/20%Monthly2018-06-04 14:26
https://www.bigmoleculewatch.com/2017/04/26/supreme-court-oral-argument-in-sandoz-v-amgen/20%Monthly2018-06-04 14:27
https://www.bigmoleculewatch.com/2017/04/25/reminder-supreme-court-arguments-tomorrow-in-amgen-v-sandoz/20%Monthly2018-05-25 18:38
https://www.bigmoleculewatch.com/2017/04/25/glenmark-pharmaceuticals-begins-clinical-investigation-for-omalizumab-biosimilar/20%Monthly2018-01-09 17:00
https://www.bigmoleculewatch.com/2017/04/24/sandozs-biosimilars-rituximab-and-etanercept-are-recommended-for-approval-in-europe/20%Monthly2018-01-09 17:02
https://www.bigmoleculewatch.com/2017/04/24/fda-advisory-committee-to-hold-public-meeting-on-hospiras-proposed-epogenprocrit-biosimilar/20%Monthly2018-01-09 17:03
https://www.bigmoleculewatch.com/2017/04/21/fda-approves-samsung-bioepiss-biosimilar-of-remicade/20%Monthly2018-01-09 17:04
https://www.bigmoleculewatch.com/2017/04/21/legislative-update-state-biosimilar-substitution-laws/20%Monthly2017-05-04 22:31
https://www.bigmoleculewatch.com/2017/04/20/appeal-for-legislative-action-to-address-rems-concerns/20%Monthly2018-07-25 15:54
https://www.bigmoleculewatch.com/2017/04/20/celltrion-files-for-approval-to-sell-herzuma-trastuzumab-in-japan/20%Monthly2018-01-09 17:06
https://www.bigmoleculewatch.com/2017/04/19/amgen-files-reply-brief-in-sandoz-v-amgen/20%Monthly2018-07-25 15:55
https://www.bigmoleculewatch.com/2017/04/19/delaware-court-declines-to-enter-judgment-in-genentech-v-amgen/20%Monthly2018-05-25 18:35
https://www.bigmoleculewatch.com/2017/04/18/house-and-senate-committees-release-draft-bill-that-reauthorizes-the-user-fee-program-for-biosimilars/20%Monthly2018-07-25 15:56
https://www.bigmoleculewatch.com/2017/04/17/amgen-responds-to-genentechs-letter/20%Monthly2018-07-25 15:56
https://www.bigmoleculewatch.com/2017/04/14/genentech-will-not-file-amended-complaint-in-case-against-amgen/20%Monthly2018-05-25 18:35
https://www.bigmoleculewatch.com/2017/04/14/summary-of-sandozs-response-and-reply-brief-in-sandoz-v-amgen/20%Monthly2018-06-04 14:28
https://www.bigmoleculewatch.com/2017/04/13/aragen-bioscience-files-three-petitions-for-ipr-on-cell-line-patents/20%Monthly2018-01-09 17:52
https://www.bigmoleculewatch.com/2017/04/11/legislation-tracker-improving-access-to-affordable-prescription-drugs-act/20%Monthly2017-05-11 21:05
https://www.bigmoleculewatch.com/2017/04/10/amgen-v-hospira-federal-circuit-oral-argument-held/20%Monthly2018-07-25 16:00
https://www.bigmoleculewatch.com/2017/04/07/celltrion-george-steuart-infliximab/20%Monthly2018-01-09 17:54
https://www.bigmoleculewatch.com/2017/04/06/immunex-files-complaint-against-sanofi-and-regeneron/20%Monthly2018-07-25 16:00
https://www.bigmoleculewatch.com/2017/04/06/ipr-tracker-ipr2016-00258-fwd/20%Monthly2018-01-09 17:59
https://www.bigmoleculewatch.com/2017/04/05/chinas-fda-accepts-jhl-biotechs-clinical-trial-application-for-rituximab-biosimilar-in-nhl/20%Monthly2018-01-09 18:00
https://www.bigmoleculewatch.com/2017/04/04/further-recent-biologics-applications/20%Monthly2018-01-09 18:01
https://www.bigmoleculewatch.com/2017/04/03/amgen-fda-priority-review-blincyto/20%Monthly2018-01-09 18:02